BioPharma Resources

Drug Trial Radar · NCT07064759

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 480 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

480

Planned (sponsor's estimate)

Start

Jul 22, 2025

Primary completion

Nov 2027

Study completion Nov 2029

Sponsor

Lead sponsor
4D Molecular TherapeuticsIndustry
Sponsor type
Industry
First posted
Jul 15, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This Phase 3 study is evaluating the safety and efficacy of 4D-150 versus aflibercept in participants with neovascular age-related macular degeneration (nAMD). Enrollment in the primary global cohort has been completed; Study centers in Japan remain open for enrollment for the Japan cohort.

Conditions

  • Neovascular Age-Related Macular Degeneration (nAMD)

Interventions

  • 4D-150 IVT (3E10 vg/eye)Biological

    If randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1

  • EYLEA® (aflibercept) Injection 2 mg (0.05mL)Biological

    Eylea (aflibercept) will be administered at applicable visits

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in Best Corrected Visual Acuity (BCVA) Early Treatment for Diabetic Retinopathy (ETDRS) letter score at Week 52Time frame: 52 Weeks

Locations

126 sites in 17 countries. Site status is shown where the registry gives one.

  • Research Network Arizona

    Scottsdale, Arizona · Active not recruiting

  • Barnet Dulaney Perkins Eye Center

    Sun City, Arizona · Active not recruiting

  • Retina Associates

    Tucson, Arizona · Active not recruiting

  • Retinal Diagnostic Center

    Campbell, California · Active not recruiting

  • Retina Consultants of Orange County

    Fullerton, California · Active not recruiting

  • Northern California Retina Vitreous Associates

    Mountain View, California · Active not recruiting

  • Retinal Consultants Medical Group Inc.

    Sacramento, California · Active not recruiting

  • Retinal Consultants Medical Group

    Sacramento, California · Active not recruiting

  • West Coast Retina Medical Group

    San Francisco, California · Active not recruiting

  • Bay Area Retina Associates

    Walnut Creek, California · Active not recruiting

  • Retina Consultants of Southern Colorado P.C.

    Colorado Springs, Colorado · Active not recruiting

  • Retina Specialists of Colorado

    Denver, Colorado · Active not recruiting

  • Southwest Retina Consultants

    Durango, Colorado · Active not recruiting

  • ClearVista Clinical Research

    Hudson, Florida · Active not recruiting

  • Florida Retina Consultants

    Lakeland, Florida · Active not recruiting

  • Florida Retina Institute

    Orlando, Florida · Active not recruiting

  • Retina Specialty Institute

    Pensacola, Florida · Active not recruiting

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida · Active not recruiting

  • East Florida Eye Institute

    Stuart, Florida · Active not recruiting

  • Retina Vitreous Associates of Florida

    Tampa, Florida · Active not recruiting

  • Thomas Eye Group

    Sandy Springs, Georgia · Active not recruiting

  • Retina Associates, Ltd.

    Elmhurst, Illinois · Active not recruiting

  • University Retina and Macula Associates, PC

    Oak Forest, Illinois · Active not recruiting

  • Illinois Retina Associates

    Oak Park, Illinois · Active not recruiting

  • Springfield Clinic

    Springfield, Illinois · Active not recruiting

  • Retina Partners Midwest, PC

    Carmel, Indiana · Active not recruiting

  • Haik Humble Eye Center

    West Monroe, Louisiana · Active not recruiting

  • The Retina Care Center

    Baltimore, Maryland · Active not recruiting

  • Cumberland Valley Retina Consultants

    Hagerstown, Maryland · Active not recruiting

  • Mid Atlantic Retina Specialists

    Hagerstown, Maryland · Active not recruiting

  • New England Retina Consultants

    Springfield, Massachusetts · Active not recruiting

  • Foundation for Vision Research

    Grand Rapids, Michigan · Active not recruiting

  • The Retina Institute

    St Louis, Missouri · Active not recruiting

  • Sierra Eye Associates

    Reno, Nevada · Active not recruiting

  • Envision Ocular, LLC

    Bloomfield, New Jersey · Active not recruiting

  • Retina Vitreous Surgeons of CNY PC

    Liverpool, New York · Active not recruiting

  • New York Presbyterian Hospital - Columbia University Medical Center

    New York, New York · Active not recruiting

  • Vitreoretinal Consultants of NY

    Westbury, New York · Active not recruiting

  • North Carolina Retina Associates

    Cary, North Carolina · Active not recruiting

  • North Carolina Retina Associates

    Wake Forest, North Carolina · Active not recruiting

Showing 40 of 126 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.